MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CLRB has $14,978,321 in assets. $5,059,134 in debts. $13,196,033 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
295.56%
Quick Ratio
295.56%
Cash Ratio
277.83%
Debt to Asset Ratio
33.78%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Property, plant & equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued lia...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
13,196,033
Prepaid expenses and other current assets
842,432
Total current assets
14,038,465
Property, plant & equipment, net
549,405
Operating lease right-of-use asset
360,671
Other long-term assets
29,780
Total assets
14,978,321
Accounts payable and accrued liabilities
4,423,548
Warrant liability
226,000
Lease liability, current
100,189
Total current liabilities
4,749,737
Lease liability, net of current portion
309,397
Total liabilities
5,059,134
Series d convertible preferred stock, 111.11 shares authorized 111.11 shares issued and outstanding as of december 31, 2025 and 2024-Series DConvertible Preferred Stock
1,382,023
Series e-2 preferred stock, 1,225.00 shares authorized 35.60 and 35.60 shares issued and outstanding as of december 31, 2025 and 2024, respectively-Series E2Preferred Stock
520,778
Common stock, 0.00001 par value 170,000,000 shares authorized 4,240,129 and 1,535,996 shares issued and outstanding as of december 31, 2025 and 2024, respectively
42
Additional paid-in capital
277,149,844
Accumulated deficit
-269,133,500
Total stockholders' equity
8,537,164
Total liabilities and stockholders' equity
14,978,321
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$13,196,033 Prepaid expenses andother current assets$842,432 Total current assets$14,038,465 Property, plant &equipment, net$549,405 Operating leaseright-of-use asset$360,671 Other long-termassets$29,780 Total assets$14,978,321 Total liabilities andstockholders' equity$14,978,321 Total stockholders'equity$8,537,164 Total liabilities$5,059,134 Series d convertiblepreferred stock, 111.11...$1,382,023 Accumulated deficit-$269,133,500 Additional paid-in capital$277,149,844 Total currentliabilities$4,749,737 Lease liability, netof current portion$309,397 Series e-2 preferredstock, 1,225.00 shares...$520,778 Common stock, 0.00001par value...$42 Accounts payable andaccrued liabilities$4,423,548 Warrant liability$226,000 Lease liability,current$100,189

Cellectar Biosciences, Inc. (CLRB)

Cellectar Biosciences, Inc. (CLRB)